A first-in-class nanoparticle injection sneaks antibodies into pancreatic cancer cells to clear mutant KRAS, shrinking tumors ...

So as daunting as a cure for cancer remains, I am certain that AI will contribute to it. And if curing cancer were the only ...

In 2020, Jennifer Doudna won the Nobel Prize in chemistry for her work on the CRISPR-Cas9 gene-editing technology that allows ...

Verastem Oncology reported positive early-stage data for its experimental cancer drug VS-7375, which is being developed to treat cancers driven by KRAS G12D mutations. The company said the drug showed ...

Researchers have found that a genetic mutation associated with a rare group of blood cancers does not always result in ...

A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how the drug works.

A team of scientists from the Barbara Ann Karmanos Cancer Institute, Wayne State University and institutions across the U.S.

A new medication could double survival time in patients with advanced pancreatic cancer, according to Phase III clinical ...

It's a fundamental principle of science: Correlation does not equal causation. Every cancer cell has genetic mutations, but not all of those mutations necessarily drive the cancer. A Harvard Medical ...

Researchers discovered that mutations linked to blood cancers may help trigger Alzheimer’s disease by creating overly ...

A late-stage trial found a new pill, daraxonrasib, doubled median survival and improved quality of life, compared with ...

Sperm from a single donor in Europe has reportedly been used to conceive at least 67 pregnancies, although the donor carried a rare cancer-causing mutation. The donor’s mutation has been linked to ...